Un Audited Financial Results For The Quarter Ended 30Th June, 2017
07-08-2017
Earnings Call With Investors / Analysts
The Company will host an Earnings Call with Investors / Analysts at 11.00 a.m. on 8th August, 2017 to disseminate Financial Results of the company for the quarter ended 30th June, 2017. A copy of the same is enclosed for your ready reference.02-08-2017
Board to consider Q1 results & Interim Dividend on August 07, 2017
Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on August 07, 2017, inter alia, to consider the following items of businesses and related matters:1. Unaudited financial results for the quarter ended June 30, 2017 (Q1) along with the Limited Review Report thereon.2. To Consider Interim Dividend, if any, for the year 2017-18....29-07-2017
Closure of Trading Window
Please further note that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 TRADING WINDOW for dealing in the securities of the Company will be closed from 31st July 2017 to 9th August 2017 (both days inclusive). Trading window will be opened from 10th August 2017.29-07-2017
Board Meeting To Be Held On 7Th August, 2017
1. Un-audited financial results for the quarter ended 30th June, 2017 along with the Limited Review Report thereon. 2. To Consider Interim Dividend, if any, for the year 2017-18. 3. Convening of 34th Annual General Meeting to be held for the financial year 2016-17. 4. Consideration of Natco Employee Stock Option Scheme 2017 (NATSOP 2017) under SEBI (Share Based Employee Benefits) Regulations, 201429-07-2017
Natco Pharma receives FDA inspection report on Kothur formulations facility
EIR is given when the unit meets the expectations of the US drug regulator on CGMP regulations20-07-2017
Press Release
NATCO RECEIVES ESTABLISHMENT INSPECTION REPORT (EIR) FROM U.S. FOOD AND DRUG ADMINISTRATION (FDA)20-07-2017
Statement Of Investors Complaints For The Quarter Ending June 2017
Investor Complaints for the quarter ending June 201714-07-2017
Shareholding for the Period Ended June 30, 2017
Natco Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here11-07-2017
Natco stands out with its niche portfolio
Complex product pipeline for US and specialty focus in domestic biz will drive growth for many years08-07-2017